BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 25154332)

  • 1. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.
    Bachhuber MA; Saloner B; Cunningham CO; Barry CL
    JAMA Intern Med; 2014 Oct; 174(10):1668-73. PubMed ID: 25154332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
    Phillips E; Gazmararian J
    J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011.
    Kim JH; Martins SS; Shmulewitz D; Hasin D
    Int J Drug Policy; 2022 Jan; 99():103449. PubMed ID: 34587580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the effect of Colorado's recreational marijuana policy on opioid overdose rates.
    Alcocer JJ
    Public Health; 2020 Aug; 185():8-14. PubMed ID: 32505041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Opioid and Benzodiazepine Poisoning Deaths After Cannabis Legalization in the US: A County-level Analysis, 2002-2020.
    Castillo-Carniglia A; Rivera-Aguirre A; Santaella-Tenorio J; Fink DS; Crystal S; Ponicki W; Gruenewald P; Martins SS; Keyes KM; Cerdá M
    Epidemiology; 2023 Jul; 34(4):467-475. PubMed ID: 36943813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
    Nguyen HV; McGinty EE; Mital S; Alexander GC
    JAMA Health Forum; 2024 Jan; 5(1):e234897. PubMed ID: 38241056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
    Wen H; Hockenberry JM
    JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study.
    Hsu G; Kovács B
    BMJ; 2021 Jan; 372():m4957. PubMed ID: 33504472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis.
    Hall W; West R; Marsden J; Humphreys K; Neale J; Petry N
    Addiction; 2018 Jun; 113(6):987-988. PubMed ID: 29468760
    [No Abstract]   [Full Text] [Related]  

  • 11. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.
    Bradford AC; Bradford WD; Abraham A; Bagwell Adams G
    JAMA Intern Med; 2018 May; 178(5):667-672. PubMed ID: 29610897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes.
    McGinty EE; Tormohlen KN; Barry CL; Bicket MC; Rutkow L; Stuart EA
    Implement Sci; 2021 Jan; 16(1):2. PubMed ID: 33413454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between medical cannabis laws and opioid overdose mortality has reversed over time.
    Shover CL; Davis CS; Gordon SC; Humphreys K
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12624-12626. PubMed ID: 31182592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of cannabis in response to the opioid crisis: A review of the literature.
    Vyas MB; LeBaron VT; Gilson AM
    Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State prescribing cap laws' association with opioid analgesic prescribing and opioid overdose.
    Tormohlen KN; McCourt AD; Schmid I; Stone EM; Stuart EA; Davis C; Bicket MC; McGinty EE
    Drug Alcohol Depend; 2022 Nov; 240():109626. PubMed ID: 36115221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-overdose laws association with opioid use and overdose mortality.
    McClellan C; Lambdin BH; Ali MM; Mutter R; Davis CS; Wheeler E; Pemberton M; Kral AH
    Addict Behav; 2018 Nov; 86():90-95. PubMed ID: 29610001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review.
    Campbell G; Hall W; Nielsen S
    Int Rev Psychiatry; 2018 Oct; 30(5):91-106. PubMed ID: 30522342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal Analysis of the Association Between Pain Management Clinic Laws and Opioid Prescribing and Overdose Deaths.
    Cerdá M; Wheeler-Martin K; Bruzelius E; Ponicki W; Gruenewald P; Mauro C; Crystal S; Davis CS; Keyes K; Hasin D; Rudolph KE; Martins SS
    Am J Epidemiol; 2021 Dec; 190(12):2592-2603. PubMed ID: 34216209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.